The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Production Of Glycoproteins With Low N-Glycolylneuraminic Acid (Neu5Gc) Content - EP2501799

The patent EP2501799 was granted to LEK Pharmaceuticals DD on Jan 24, 2018. The application was originally filed on Nov 19, 2010 under application number EP10781888A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2501799

LEK PHARMACEUTICALS DD
Application Number
EP10781888A
Filing Date
Nov 19, 2010
Status
Granted And Under Opposition
Dec 22, 2017
Publication Date
Jan 24, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MAIWALDOct 24, 2018MAIWALDADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0092037
DESCRIPTIONEP0543106
DESCRIPTIONUS2007161084
DESCRIPTIONUS5459031
INTERNATIONAL-SEARCH-REPORTUS2007161084
INTERNATIONAL-SEARCH-REPORTWO2008128227
OPPOSITIONUS2007161084
OPPOSITIONWO2004008100
OPPOSITIONWO2008128227

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents